All posts tagged
Celyad gets FDA Fast Track to Tackle Heart Failure with Cell Therapy
Taking Cell Therapy one Step Further with this Boost Reagent
“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”
New Cardiac Stem Cell Therapy passes Phase I/II Trials
It’s Not Just Regulations: 9 Other Reasons Advanced Therapies Fail
Stem Cell Therapy from the UK fights Cardiovascular Disease
Can Biotech Stop the Diabetes Epidemic? Reviewing the Hottest Technology
Meet the CEO making the Next Generation of Gene Therapies Possible
Cell Therapies: Is Commercialization holding back a Breakthrough?
UPDATE: FDA Lifts Hold on Adaptimmune’s Rare Cancer Trials
Why are there only 8 cell and gene therapies on the EU Market?
UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease
Labiotech UG, All Rights Reserved -
Send this to friend